VCAM-targeted delivery of recombinant CD39 to the endothelium is antithrombotic, antiinflammatory and ameliorates ischaemia reperfusion injury

Nandurkar, Harshal (Primary Chief Investigator (PCI))

Australian Centre for Blood Diseases

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/18

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$603,813.00

1 Article

The mode of anesthesia influences outcome in mouse models of arterial thrombosis
Sashindranath, M., Sturgeon, S., French, S. L., Craenmehr, D. D. D., Selan, C., Freddi, S., Johnson, C., Cody, S., Nesbitt, W., Hamilton, J., Cody, S. H., Nesbitt, W., Hamilton, J. & Nandurkar, H., Apr 2019, In: Research and Practice in Thrombosis and Haemostasis. 3, 2, p. 197-206 10 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

6 Citations (Scopus)